Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic considerations in composite tissue transplantation: overview.

L Cendales1, M A Hardy

  • 1Christine M. Kleinert Institute for Hand and Microsurgery, Louisville, Kentucky, USA.

Microsurgery
|January 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Kidneys at higher risk of discard: expanding the role of dual kidney transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Banff 2011 Meeting report: new concepts in antibody-mediated rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Vascularized composite allotransplantation research: the emerging field.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012

Composite tissue allografting (CTA) for upper extremity transplantation requires careful immunosuppression management. Understanding the immunologic aspects of CTA is crucial for achieving long-term graft survival and patient tolerance.

Area of Science:

  • Immunology
  • Transplantation Surgery
  • Regenerative Medicine

Background:

  • Composite tissue allografting (CTA) for upper extremity transplantation is a developing field.
  • Unlike organ transplant recipients, CTA candidates are typically healthy patients.
  • CTA shares similarities with immediately vascularized organ allografts, necessitating immunologic understanding.

Purpose of the Study:

  • To summarize immunosuppressive management in hand allograft recipients.
  • To explore immunologic advantages, disadvantages, and graft toxicity of immunosuppressive agents.
  • To outline key considerations for achieving tolerance in CTA.

Main Methods:

  • Review of immunosuppressive strategies in clinical upper extremity transplantation.
  • Analysis of immunologic considerations including pre-transplant recipient factors and donor pretreatment.

Related Experiment Videos

  • Evaluation of immunosuppression for induction, maintenance, and acute rejection treatment.

    • Main Results:

    • Successful clinical upper extremity transplantation has been achieved.
    • Immunologic understanding of CTA is still evolving with clinical experience.
    • Commonly used immunosuppressive agents have associated advantages, disadvantages, and toxicities.

    Conclusions:

    • Optimizing immunosuppression is key to successful composite tissue allografting.
    • Addressing recipient, donor, and immunosuppression factors is vital for graft survival.
    • Future research should focus on tolerance induction strategies for long-term outcomes.